European Journal of Cancer
Volume 39, Issue 6 , Pages 728-735 , April 2003

Potential role of magnetic resonance spectroscopy in assessment of tumour response in childhood cancer

  • S.J. Vaidya

      Affiliations

    • Department of Paediatric Oncology, Institute of Cancer Research and The Royal Marsden NHS Trust, Sutton, Surrey SM2 5PT, UK
    • ,
  • Geoffrey S. Payne

      Affiliations

    • Cancer Research UK Clinical Magnetic Resonance Research Group, Institute of Cancer Research and The Royal Marsden NHS Trust, Sutton, Surrey SM2 5PT, UK
    • ,
  • Martin O. Leach

      Affiliations

    • Cancer Research UK Clinical Magnetic Resonance Research Group, Institute of Cancer Research and The Royal Marsden NHS Trust, Sutton, Surrey SM2 5PT, UK
    • ,
  • C.R. Pinkerton

      Affiliations

    • Department of Paediatric Oncology, Institute of Cancer Research and The Royal Marsden NHS Trust, Sutton, Surrey SM2 5PT, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44-20-8661-3957; fax: +44-20-8661-3617

Received 29 April 2002 ,Revised 25 October 2002 ,Accepted 8 November 2002.

References 

  1. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hanicke W, Sauter R. Localized high-resolution proton NMR spectroscopy using stimulated echoes (initial applications to human brain in vivo). Magn. Reson. Med. 1989;9:79–93
  2. Frahm J, Merboldt KD, Hanicke W. Localized proton spectroscopy using stimulated echoes. J. Magn. Reson. 1987;72:502–508
  3. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann. N.Y. Acad. Sci. 1987;508:333–348
  4. Ordidge R, Connelly A, Lohman J. Image-selected in vivo spectroscopy (ISIS). A new technique for spatially selective NMR spectroscopy. J. Magn. Reson. 1986;66:283–294
  5. Brown TR, Kincaid BM, Ugurbil K. NMR chemical shift imaging in three dimensions. Proc. Natl. Acad. Sci. USA. 1982;79:3523–3526
  6. Brown TR. Practical applications of chemical shift imaging. NMR Biomed. 1992;5:238–243
  7. Moonen CT, von Kienlin M, van Zijl PC, et al.  Comparison of single-shot localization methods (STEAM and PRESS) for in vivo proton NMR spectroscopy. NMR Biomed. 1989;2:201–208
  8. Freeman DM, Hurd R. Decoupling (theory and practice. II. State of the art: in vivo applications of decoupling). NMR Biomed. 1997;10:381–393
  9. Luyten PR, Bruntink G, Sloff FM, et al.  Broadband proton decoupling in human 31P NMR spectroscopy. NMR Biomed. 1989;1:177–183
  10. Podo F. Tumour phospholipid metabolism. NMR Biomed. 1999;12:413–439
  11. Leach MO, Le Moyec L, Podo F. MRS of tumours: basic principles. In:  de Certaines JD,  Bovee W,  Podo F editor. Magnetic Resonance Spectroscopy in Biology and Medicine. UK: Pergamon Press; 1992;p. 295–344
  12. Stubbs M. Application of magnetic resonance techniques for imaging tumour physiology. Acta Oncol. 1999;38:845–853
  13. Evelhoch JL, Gillies RJ, Karczmar GS, et al.  Applications of magnetic resonance in model systems (cancer therapeutics). Neoplasia. 2000;2:152–165
  14. Ojugo AS, McSheehy PM, Stubbs M, et al.  Influence of pH on the uptake of 5-fluorouracil into isolated tumour cells. Br. J. Cancer. 1998;77:873–879
  15. Ronen SM, Jackson LE, Beloueche M, Leach MO. Magnetic resonance detects changes in phosphocholine associated with Ras activation and inhibition in NIH 3T3 cells. Br. J. Cancer. 2001;84:691–696
  16. Findlay MP, Leach MO. In vivo monitoring of fluoropyrimidine metabolites (magnetic resonance spectroscopy in the evaluation of 5-fluorouracil). Anticancer Drugs. 1994;5:260–280
  17. Payne GS, Pinkerton CR, Bouffet E, Leach MO. Initial measurements of ifosfamide and cyclophosphamide in patients using 31P MRS (pulse-and-acquire, decoupling, and polarization transfer). Magn. Reson. Med. 2000;44:180–184
  18. Griffiths JR, Stevens AN, Iles RA, Gordon RE, Shaw D. 31P-NMR investigation of solid tumours in the living rat. Biosci. Rep. 1981;1:319–325
  19. Jackel MC, Kopf-Maier P, Baumgart F, Ziessow D, Tausch-Treml R. Value of 31P NMR spectroscopy in predicting the response of a xenografted human hypopharynx carcinoma to irradiation. J. Cancer Res. Clin. Oncol. 2000;126:325–331
  20. Street JC, Mahmood U, Matei C, Koutcher JA. In vivo and in vitro studies of cyclophosphamide chemotherapy in a mouse mammary carcinoma by 31P NMR spectroscopy. NMR Biomed. 1995;8:149–158
  21. Tausch-Treml R, Kopf-Maier P, Baumgart F, et al.  31P nuclear magnetic resonance spectroscopy, histology and cytokinetics of a xenografted hypopharynx carcinoma following treatment with cisplatin (comparison in three sublines with increasing resistance). Br. J. Cancer. 1991;64:485–493
  22. de Certaines JD, Albrectsen J, Larsen VA, Xie X, Rygaard J, Henriksen O. In vivo 31P magnetic resonance spectroscopy and 1H magnetic resonance imaging of human bladder carcinoma on nude mice (effects of tumour growth and treatment with cis-dichloro-diamine platinum). In Vivo. 1992;6:611–616
  23. de Certaines JD, Larsen VA, Podo F, Carpinelli G, Briot O, Henriksen O. In vivo 31P MRS of experimental tumours. NMR Biomed. 1993;6:345–365
  24. Koutcher JA, Alfieri AA, Devitt ML, et al.  Quantitative changes in tumor metabolism, partial pressure of oxygen, and radiobiological oxygenation status postradiation. Cancer Res. 1992;52:4620–4627
  25. Negendank W. Studies of human tumors by MRS (a review). NMR Biomed. 1992;5:303–324
  26. Koutcher JA, Ballon D, Graham M, et al.  31P NMR spectra of extremity sarcomas (diversity of metabolic profiles and changes in response to chemotherapy). Magn. Reson. Med. 1990;16:19–34
  27. Redmond OM, Bell E, Stack JP, et al.  Tissue characterization and assessment of preoperative chemotherapeutic response in musculoskeletal tumors by in vivo 31P magnetic resonance spectroscopy. Magn. Reson. Med. 1992;27:226–237
  28. Moller HE, Vermathen P, Rummeny E, et al.  In vivo 31P NMR spectroscopy of human musculoskeletal tumors as a measure of response to chemotherapy. NMR Biomed. 1996;9:347–358
  29. Maris JM, Evans AE, McLaughlin AC, et al.  31P nuclear magnetic resonance spectroscopic investigation of human neuroblastoma in situ. N. Engl. J. Med. 1985;312:1500–1505
  30. Arias-Mendoza F, Brown, TR, Charles HC, et al. Methodological standardization for a multi-institutional in vivo trial of localized 31P MR spectroscopy in human cancer research. In Proceedings of the 7th Annual Meeting of the International Society of Magnetic Resonance in Medicine, 1999, 1585 (abstr).
  31. Arias-Mendoza F, Brown TR, Schwartz AJ, et al. Preliminary results of a multi-instituitional trial to demonstrate clinical predictive value of in vivo localized 31P MR spectroscopy data in human non-Hodgkin's lymphoma. In Proceedings of the 8th Annual Meeting of the International Society of Magnetic Resonance in Medicine, 2000, 98 (abstr).
  32. Arias-Mendoza F, Zakian K, Stubbs M, et al. Investigation of the predictive value of the pretreatment tumour content of phosphoethanolamine and phosphocholine measured by in vivo 31P MR spectroscopy in non-Hodgkin's lymphoma in a multi-instituitional setting. In Proceedings of the 9th Annual Meeting of the International Society of MAgnetic Resonance in Medicine, 2001, 274 (abstr).
  33. Bizzi A, Movsas B, Tedeschi G, et al.  Response of non-Hodgkin lymphoma to radiation therapy (early and long-term assessment with H-1 MR spectroscopic imaging). Radiology. 1995;194:271–276
  34. Bryant DJ, Bydder GM, Case HA, et al.  Use of phosphorus-31 MR spectroscopy to monitor response to chemotherapy in non-Hodgkin lymphoma. J. Comput. Assist. Tomogr. 1988;12:770–774
  35. Negendank WG, Padavic-Shaller KA, Li CW, et al.  Metabolic characterization of human non-Hodgkin's lymphomas in vivo with the use of proton-decoupled phosphorus magnetic resonance spectroscopy. Cancer Res. 1995;55:3286–3294
  36. Smith SR, Martin PA, Davies JM, Edwards RH, Stevens AN. The assessment of treatment response in non-Hodgkin's lymphoma by image guided 31P magnetic resonance spectroscopy. Br. J. Cancer. 1990;61:485–490
  37. Kuliszkiewicz-Janus M, Baczynski S. Application of 31P NMR spectroscopy to monitor chemotherapy-associated changes of serum phospholipids in patients with malignant lymphomas. Magn. Reson. Med. 1996;35:449–456
  38. Heesters MA, Kamman RL, Mooyaart EL, Go KG. Localized proton spectroscopy of inoperable brain gliomas. Response to radiation therapy. J. Neurooncol. 1993;17:27–35
  39. Negendank WG, Sauter R, Brown TR, et al.  Proton magnetic resonance spectroscopy in patients with glial tumors (a multicenter study). J. Neurosurg. 1996;84:449–458
  40. Wang Z, Sutton LN, Cnaan A, et al.  Proton MR spectroscopy of pediatric cerebellar tumors. AJNR Am. J. Neuroradiol. 1995;16:1821–1833
  41. Tedeschi G, Lundbom N, Raman R, et al.  Increased choline signal coinciding with malignant degeneration of cerebral gliomas (a serial proton magnetic resonance spectroscopy imaging study). J. Neurosurg. 1997;87:516–524
  42. Taylor JS, Langston JW, Reddick WE, et al.  Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis. Int. J. Radiat. Oncol. Biol. Phys. 1996;36:1251–1261
  43. Hwang JH, Egnaczyk GF, Ballard E, Dunn RS, Holland SK, Ball WS. Proton MR spectroscopic characteristics of pediatric pilocytic astrocytomas. AJNR Am. J. Neuroradiol. 1998;19:535–540
  44. Lin A, Bluml S, Mamelak AN. Efficacy of proton magnetic resonance spectroscopy in clinical decision making for patients with suspected malignant brain tumors. J. Neurooncol. 1999;45:69–81
  45. Preul MC, Caramanos Z, Collins DL, et al.  Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat. Med. 1996;2:323–325
  46. Warren KE, Frank JA, Black JL, et al.  Proton magnetic resonance spectroscopic imaging in children with recurrent primary brain tumors. J. Clin. Oncol. 2000;18:1020–1026
  47. Lazareff JA, Gupta RK, Alger J. Variation of post-treatment H-MRSI choline intensity in pediatric gliomas. J. Neurooncol. 1999;41:291–298
  48. Preul MC, Caramanos Z, Villemure JG, et al.  Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy. Neurosurgery. 2000;46:306–318
  49. Girard N, Wang ZJ, Erbetta A, et al.  Prognostic value of proton MR spectroscopy of cerebral hemisphere tumors in children. Neuroradiology. 1998;40:121–125

PII: S0959-8049(02)00728-1

doi: 10.1016/S0959-8049(02)00728-1

European Journal of Cancer
Volume 39, Issue 6 , Pages 728-735 , April 2003

Article Tools

* Image Usage & Resolution